Susan Weng Larsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Susan Weng Larsen has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Jesper Østergaard
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; LEO Foundation Center for Cutaneous Drug Delivery, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
48 shared publications Claus Larsen
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark
26 shared publications- Anan Yaghmur
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
20 shared publications Henrik Jensen
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen DK-2100, Denmark
13 shared publications- Henrik Jensen
FIDA Biosystems ApS Søborg 2860 Denmark
8 shared publications Fengbin Ye
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen, Denmark
7 shared publications
Latest Publications
- Open Access
- 15 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Development of a bio-relevant in vitro release testing method for subcutaneous and intramuscular oil depot formulations
- 15 November 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Open AccessDevelopment of a bio-relevant in vitro release testing method for subcutaneous and intramuscular oil depot formulations
- Open Access
- 1 June 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 623, 121880
Investigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV–Vis imaging and SAXS
- 1 June 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 623, 121880
Open AccessInvestigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV–Vis imaging and SAXS
- Open Access
- 25 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3599
Methodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance
A UV imaging release-testing setup comprising an agarose gel as a model for tumorous tissue was developed. The setup was optimized with respect to agarose concentration (0.5% (w/v)), injection procedure, and temperature control. A repeatable injection protocol was established allowing injection into cavities with well-defined geometries. The effective resolution of the SDi2 UV imaging system is 30–80 µm. The linear range of the imaging system is less than that of typical spectrophotometers. Consequently, non-linear cAMP calibration curves were applied for quantification at 280 nm. The degree of deviation from Beer’s law was affected by the background absorbance of the gel matrix. MATLAB scripts provided hitherto missing flexibility with respect to definition and utilization of quantification zones, contour lines facilitating visualization, and automated, continuous data analysis. Various release patterns were observed for an aqueous solution and in situ forming Pluronic F127 hydrogel and PLGA implants containing cAMP as a model for STING ligands. The UV imaging and MATLAB data analysis setup constituted a significant technical development in terms of visualizing behavior for injectable formulations intended for intra-tumoral delivery, and, thereby, a step toward establishment of a bio-predictive in vitro release-testing method.
- 25 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3599
Open AccessMethodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance
A UV imaging release-testing setup comprising an agarose gel as a model for tumorous tissue was developed. The setup was optimized with respect to agarose concentration (0.5% (w/v)), injection procedure, and temperature control. A repeatable injection protocol was established allowing injection into cavities with well-defined geometries. The effective resolution of the SDi2 UV imaging system is 30–80 µm. The linear range of the imaging system is less than that of typical spectrophotometers. Consequently, non-linear cAMP calibration curves were applied for quantification at 280 nm. The degree of deviation from Beer’s law was affected by the background absorbance of the gel matrix. MATLAB scripts provided hitherto missing flexibility with respect to definition and utilization of quantification zones, contour lines facilitating visualization, and automated, continuous data analysis. Various release patterns were observed for an aqueous solution and in situ forming Pluronic F127 hydrogel and PLGA implants containing cAMP as a model for STING ligands. The UV imaging and MATLAB data analysis setup constituted a significant technical development in terms of visualizing behavior for injectable formulations intended for intra-tumoral delivery, and, thereby, a step toward establishment of a bio-predictive in vitro release-testing method.
- Open Access
- 1 November 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 609, 121183
An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants
- 1 November 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 609, 121183
Open AccessAn in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants
- 1 February 2021
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 194, 113789
Towards functional characterization of excipients for oral solid dosage forms using UV–vis imaging. Liberation, release and dissolution
- 1 February 2021
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 194, 113789
Towards functional characterization of excipients for oral solid dosage forms using UV–vis imaging. Liberation, release and dissolution
- 1 January 2021
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 582 (Pt B) , 773-781
In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid
- 1 January 2021
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 582 (Pt B) , 773-781
In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid
- 1 April 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (4) , 1529-1536
Diclofenac Prodrugs for Intra-articular Depot Injectables: In Vitro Hydrolysis and Species Variation
- 1 April 2020
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (4) , 1529-1536
Diclofenac Prodrugs for Intra-articular Depot Injectables: In Vitro Hydrolysis and Species Variation
- 1 March 2020
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 145, 105239
Towards in vitro in vivo correlation for modified release subcutaneously administered insulins
- 1 March 2020
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 145, 105239
Towards in vitro in vivo correlation for modified release subcutaneously administered insulins